These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16378078)

  • 1. Serum sCD30 in monitoring of alloresponse in well HLA-matched cadaveric kidney transplantations.
    Matinlauri IH; Kyllönen LE; Salmela KT; Helin H; Pelzl S; Süsal C
    Transplantation; 2005 Dec; 80(12):1809-12. PubMed ID: 16378078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30.
    Süsal C; Pelzl S; Döhler B; Opelz G
    J Am Soc Nephrol; 2002 Jun; 13(6):1650-6. PubMed ID: 12039995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
    Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
    Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD30 as a predictor of kidney graft outcome.
    Pelzl S; Opelz G; Wiesel M; Schnülle P; Schönemann C; Döhler B; Süsal C
    Transplantation; 2002 Jan; 73(1):3-6. PubMed ID: 11792970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
    Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30.
    Süsal C; Pelzl S; Opelz G
    Transplantation; 2003 Oct; 76(8):1231-2. PubMed ID: 14578759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in pre- and posttransplant immunologic testing in kidney transplantation.
    Süsal C; Pelzl S; Simon T; Opelz G
    Transplant Proc; 2004; 36(1):29-34. PubMed ID: 15013292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival.
    Langan LL; Park LP; Hughes TL; Irish A; Luxton G; Witt CS; Christiansen FT
    Am J Transplant; 2007 Apr; 7(4):847-56. PubMed ID: 17391128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
    Pavlova Y; Viklicky O; Slatinska J; Bürgelova M; Süsal C; Skibova J; Honsová E; Striz I; Kolesar L; Slavcev A
    Transpl Immunol; 2011 Jul; 25(1):72-6. PubMed ID: 21376809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations.
    Cinti P; Pretagostini R; Arpino A; Tamburro ML; Mengasini S; Lattanzi R; De Simone P; Berloco P; Molajoni ER
    Transplantation; 2005 May; 79(9):1154-6. PubMed ID: 15880060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection.
    Saini D; Ramachandran S; Nataraju A; Benshoff N; Liu W; Desai N; Chapman W; Mohanakumar T
    Am J Transplant; 2008 Sep; 8(9):1798-808. PubMed ID: 18786226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts.
    Karahan GE; Caliskan Y; Ozdilli K; Kekik C; Bakkaloglu H; Caliskan B; Turkmen A; Sever MS; Oguz FS
    Int J Artif Organs; 2017 Jan; 39(11):547-552. PubMed ID: 28058698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies.
    Vaidya S; Partlow D; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(12):1606-9. PubMed ID: 17198244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens.
    Weimer R; Süsal C; Yildiz S; Staak A; Pelzl S; Renner F; Dietrich H; Daniel V; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
    Am J Transplant; 2006 Aug; 6(8):1865-74. PubMed ID: 16771810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum level of the soluble CD30 identifies Chinese kidney transplant recipients at high risk of unfavorable outcome.
    Iv R; He Q; Wang HP; Jin J; Chen Y; Chen JH
    Transplant Proc; 2008 Dec; 40(10):3375-80. PubMed ID: 19100393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.